Cargando…
Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait
OBJECTIVE: To evaluate the outcomes of patients with multiple sclerosis (MS) who were treated with natalizumab in Kuwait. MATERIALS AND METHODS: A retrospective study using the MS registry to identify patients who were treated with natalizumab was conducted. Patients’ demographics, clinical characte...
Autores principales: | Alroughani, R., Al Hashel, J., Thussu, A., Ahmed, S.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586786/ https://www.ncbi.nlm.nih.gov/pubmed/23797019 http://dx.doi.org/10.1159/000351568 |
Ejemplares similares
-
Economic burden of multiple sclerosis on Kuwait health care system
por: Alowayesh, Maryam S., et al.
Publicado: (2019) -
Natalizumab: A new treatment for relapsing remitting multiple sclerosis
por: Hutchinson, Michael
Publicado: (2007) -
Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis
por: Nakamura, Masataka, et al.
Publicado: (2017) -
A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis
por: Trojano, Maria, et al.
Publicado: (2021) -
COVID-19 Vaccination in People with Multiple Sclerosis. the Kuwait Experience
por: Alroughani, Raed, et al.
Publicado: (2022)